US Patent 10487086 Macrocycles as factor XIa inhibitors
Patent 10487086 was granted and assigned to Bristol-Myers Squibb on November, 2019 by the United States Patent and Trademark Office.
All edits
Edits on 30 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 9 Dec, 2023
Golden AI
Edits made to:
Article (+71 characters)
Article
Patent abstract
The present invention provides compounds of Formula (I):
Edits on 3 Oct, 2023
Golden AI
Edits made to:
Infobox (+11 properties)
Infobox
Patent Inventor Names
Carl P. Decicco0
Donald J. P. Pinto0
James R. Corte0
Joanne M. Smallheer0
Karen A. Rossi0
Mimi L. Quan0
Tianan Fang0
Wu Yang0
Yoon Jeon0
Yufeng Wang0
Zilun Hu0
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
104870860
Date of Patent
November 26, 2019
0Patent Application Number
157184310
Date Filed
September 28, 2017
0Patent Primary Examiner
Edits on 30 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10487086 Macrocycles as factor XIa inhibitors
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10487086
Date of patent
November 26, 2019
Patent application number
15718431
Date Filed
September 28, 2017
Patent primary examiner
Find more entities like US Patent 10487086 Macrocycles as factor XIa inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
